Early and midterm outcome of Multilayer Flow Modulator stent for complex aortic aneurysm treatment in Germany

摘要: Abstract Objective The objective of this study was to assess the early and midterm outcomes endovascular repair complex aortic aneurysm cases using Multilayer Flow Modulator (MFM; Cardiatis, Isnes, Belgium) endograft in Germany. Methods A retrospective including patients presenting with abdominal (AAA), thoracic aneurysm, or thoracoabdominal treated MFM conducted Mortality morbidity (in terms spinal cord ischemia, visceral stroke) at 30 days postoperatively were evaluated. In addition, during follow-up, freedom from reintervention, rupture, failure mode also assessed. Results Between 2009 2014, a total 61 AAA, 29 hospitals around However, data 40 mean age 73.4 ± 11.2 years (72.5% male; 29/40) diameter 60.3 ± 16.6 mm 14 available for study. Thirty-seven (93%) urgently. 12 (12/40 [30%]), outside instructions use because >65 mm. 69 stents used (1.7/patient). technical success rate 95% (38/40). Postoperatively, no patient presented renal function deterioration, stroke, intestinal except one who developed multiorgan stent migration. intraoperative 30-day mortality 0% 2.5%, respectively. follow-up 12.9 months (±14.9 months), survival 1 month, 6 months, 12 months 97%, 78%, 70%, Freedom (type I II) 97.5%, 88%, 86%, respectively, vessel patency 99.3% (155/156 available). During 4 (4/39 [10%]) had an sac rupture 10 (10/39 [25%]) underwent reintervention. reintervention 97.5% 100%, 96% 84%, 86% 75%, Conclusions treatment urgent appears be technically feasible morbidity, moderate acceptable outcomes. Reinterventions may needed expand utility